A Fixed-Depth Microneedle Enhances Reproducibility and Safety for Corneal Gene Therapy

Conclusions: Further development of the PCI microneedle is warranted especially for AAV corneal gene therapy and offers the potential to enhance transduction while significantly reducing safety concerns and intraclinician and interclinician injection variability.
Source: Cornea - Category: Opthalmology Tags: Basic Investigation Source Type: research